These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26517216)

  • 61. Clinical validity of the Mattis Dementia Rating Scale in differentiating mild cognitive impairment in Parkinson's disease and normative data.
    Bezdicek O; Michalec J; Nikolai T; Havránková P; Roth J; Jech R; Růžička E
    Dement Geriatr Cogn Disord; 2015; 39(5-6):303-11. PubMed ID: 25792240
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low Sensitivity of the Mini-Mental State Examination for Cognitive Assessment of Brazilian Patients With Parkinson Disease.
    Breder R; Leite MAA; Pinto JA; Cavalcante IP; Pessoa BL; Neves MAO
    J Geriatr Psychiatry Neurol; 2017 Nov; 30(6):311-315. PubMed ID: 28969462
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative Diagnostic Accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for Screening of Alzheimer Disease.
    Matías-Guiu JA; Valles-Salgado M; Rognoni T; Hamre-Gil F; Moreno-Ramos T; Matías-Guiu J
    Dement Geriatr Cogn Disord; 2017; 43(5-6):237-246. PubMed ID: 28384640
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Parkinson's disease dementia: Diagnostic criteria and risk factor review.
    Vasconcellos LF; Pereira JS
    J Clin Exp Neuropsychol; 2015; 37(9):988-93. PubMed ID: 26332178
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Validation of Addenbrooke's cognitive examination III for detecting mild cognitive impairment and dementia in Japan.
    Takenoshita S; Terada S; Yoshida H; Yamaguchi M; Yabe M; Imai N; Horiuchi M; Miki T; Yokota O; Yamada N
    BMC Geriatr; 2019 Apr; 19(1):123. PubMed ID: 31035933
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study.
    Lu J; Li D; Li F; Zhou A; Wang F; Zuo X; Jia XF; Song H; Jia J
    J Geriatr Psychiatry Neurol; 2011 Dec; 24(4):184-90. PubMed ID: 22228824
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Validation of the Spanish-language version of Mini-Addenbrooke's Cognitive Examination as a dementia screening tool.
    Matias-Guiu JA; Fernandez-Bobadilla R
    Neurologia; 2016; 31(9):646-648. PubMed ID: 25529174
    [No Abstract]   [Full Text] [Related]  

  • 68. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
    Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
    J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Addenbrooke's Cognitive Examination-Revised for mild cognitive impairment in Parkinson's disease.
    McColgan P; Evans JR; Breen DP; Mason SL; Barker RA; Williams-Gray CH
    Mov Disord; 2012 Aug; 27(9):1173-7. PubMed ID: 22733390
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
    Rasovska H; Rektorova I
    J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study.
    Dong Y; Yean Lee W; Hilal S; Saini M; Wong TY; Chen CL; Venketasubramanian N; Ikram MK
    Int Psychogeriatr; 2013 Nov; 25(11):1831-8. PubMed ID: 23870281
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Validation of Neuropsychological Tests to Screen for Dementia in Chinese Patients With Parkinson's Disease.
    Qiao J; Wang X; Lu W; Cao H; Qin X
    Am J Alzheimers Dis Other Demen; 2016 Jun; 31(4):368-74. PubMed ID: 26646116
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan.
    Yu RL; Wu RM; Tai CH; Lin CH; Cheng TW; Hua MS
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1067-72. PubMed ID: 22749792
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items.
    Lees RA; Hendry Ba K; Broomfield N; Stott D; Larner AJ; Quinn TJ
    Int J Geriatr Psychiatry; 2017 Oct; 32(10):1072-1078. PubMed ID: 27526678
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Addenbrooke's Cognitive Examination Revised (ACE-R) and its sub-scores: normative values in an Italian population sample.
    Siciliano M; Raimo S; Tufano D; Basile G; Grossi D; Santangelo F; Trojano L; Santangelo G
    Neurol Sci; 2016 Mar; 37(3):385-92. PubMed ID: 26563847
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population.
    Tan JP; Li N; Gao J; Wang LN; Zhao YM; Yu BC; Du W; Zhang WJ; Cui LQ; Wang QS; Li JJ; Yang JS; Yu JM; Xia XN; Zhou PY
    J Alzheimers Dis; 2015; 43(4):1403-12. PubMed ID: 25147113
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Abnormalities in auditory and visual cognitive processes are differentiated with theta responses in patients with Parkinson's disease with and without dementia.
    Güntekin B; Aktürk T; Yıldırım E; Yılmaz NH; Hanoğlu L; Yener G
    Int J Psychophysiol; 2020 Jul; 153():65-79. PubMed ID: 32339563
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease.
    Pedersen KF; Larsen JP; Aarsland D
    Parkinsonism Relat Disord; 2008; 14(3):183-6. PubMed ID: 17889589
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnostic utility of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and its combination with the Addenbrooke's Cognitive Examination-Revised (ACE-R) in a memory clinic-based population.
    Hancock P; Larner AJ
    Int Psychogeriatr; 2009 Jun; 21(3):526-30. PubMed ID: 19327203
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening.
    Mioshi E; Dawson K; Mitchell J; Arnold R; Hodges JR
    Int J Geriatr Psychiatry; 2006 Nov; 21(11):1078-85. PubMed ID: 16977673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.